Archive for the ‘Testing’ Category

Lyme & Herxheimer Reaction in Newborn

https://danielcameronmd.com/lyme-disease-herxheimer-reaction-newborn/

Lyme disease and herxheimer reaction in newborn

Newborn with lyme disease and herxheimer reaction being examined by doctor.

The Herxheimer reaction, also referred to as a Jarisch-Herxheimer reaction, is “a transient clinical phenomenon that occurs in patients infected by spirochetes who undergo antibiotic treatment.”¹ It was first described in patients with syphilis but has also been associated with other spirochetal infections including leptospirosis, Lyme disease, and relapsing fever. The reaction is associated with the onset of new symptoms or a worsening of existing symptoms in patients receiving antibiotic treatment.

In 2020, investigators published a case involving a 13-year-old boy with Lyme arthritis, a common manifestation of Lyme disease, who developed a Herxheimer reaction when treated with doxycycline. On the 7th day of treatment, the boy developed a low-grade fever and severe arthralgias with intense hip, ankle and cervical spine pain and myalgias.

You can read more about the 13-year-old boy’s case in an earlier blog “Herxheimer reaction in a 13-year-old boy with Lyme disease.” 

Newborn with herxheimer reaction

In their article “Lyme disease in a neonate complicated by the Jarisch–Herxheimer reaction,”  Prodanuk and colleagues² describe the case of a 21-day-old infant who was admitted to the hospital with decreased activity, poor feeding and abdominal distension.

The parents removed an engorged tick from the infant’s forearm 5 days earlier. An EM rash was present at the site of the tick bite.

“Given the erythema migrans lesion at the site from which the engorged tick was removed, we made a presumptive diagnosis of Lyme disease and administered IV ceftriaxone,” the authors write.

Two hours after treatment began, the infant developed a fever, tachycardia and other symptoms consistent with the Jarisch–Herxheimer reaction.

Testing for Lyme disease was negative.

Clinicians should also “be aware of the possibility of the Jarisch–Herxheimer reaction during the initial phase of treatment.”²

Several studies, they warn, indicate “newborns with findings consistent with early localized disease may also be at higher risk for disseminated disease.”

“Given the limited data for neonates and the possible predisposition of this population to disseminated Lyme disease, clinicians should strongly consider administering IV antibiotics to target Lyme disease,” the authors suggest.

Patients can experience a broad range of symptoms resulting from a herxheimer reaction, explains Nykytyuk and colleagues, including fever, severe polyarthralgias, myalgias, chills, hypotension, nonpruritic, nonpalpable rash, tachycardia, nausea, headache, strengthening of existing or occurrence of new symptoms of the underlying disease.¹

The exact cause of Jarisch-Herxheimer reactions is still unknown. “At first, the role of an endotoxin in the development of JHR was suggested, but later experimental studies showed that spirochetes do not have biologically active endotoxins,” the authors explained.¹

References:
  1. Dhakal A, Sbar E. Jarisch Herxheimer Reaction. [Updated 2022 Apr 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557820/
  2. Prodanuk M, Groves H, Arje D, Bitnun A. Lyme disease in a neonate complicated by the Jarisch-Herxheimer reaction. CMAJ. 2022 Jul 18;194(27):E939-E941. doi: 10.1503/cmaj.220112. PMID: 35851530; PMCID: PMC9299745.

______________

Lyme Disease Research in Review: Triumphs, Trials, and the Path Forward

https://www.lymedisease.org/lyme-disease-research-review/

Lyme disease research in review: triumphs, trials, and the path forward

As always, the world of Lyme is complicated with both good news and bad. Looking back over the past year, I want to highlight a few of the biggest scientific advances that stand out in my mind.

Co-Infections

First I want to share something that science keeps validating—the majority of patients with persistent symptoms following a diagnosis of Lyme disease have co-infections.

This means they are infected with two or more pathogens (such as bacteria, viruses, or fungi) at the same time. These co-infections (including COVID-19) complicate the immune response and likely increase the chance of developing chronic Lyme.

As I wrote about previously, North America is “ground zero” for babesiosis, which is likely playing a much greater role in patients with chronic Lyme than we know. In the MyLymeData study, over 60% of patients report they were diagnosed with an additional tick-borne infection along with Lyme. For most of them, it’s Babesia.

In July 2024, researchers conducting a Lyme disease pilot study at North Carolina State University discovered that all seven participants were infected with Babesia, and six out of the seven were co-infected with at least one (sometimes two or more) species of Bartonella.

Babesia is a parasite, similar to malaria. It requires a separate test and special anti-parasitic medications outside of the standard tests and antibiotics used for Lyme disease alone.

Diagnostics

As I wrote about in December 2023, Borrelia (Lyme) has some unique features allowing it to hide from our immune system. That stealth technique, which keeps the number of bacteria low in the blood stream, also makes it difficult for standard blood tests to detect Lyme disease. In April of 2024, Dr. Michal Tal and her team published another clue as to how Borrelia hides from the immune system.

Right now, all eyes are on the six teams competing in the LymeX diagnostic challenge as they move forward with their innovations. These will hopefully result in a more accurate test becoming available to the public than the standard outdated test that has been around since 1994. (Note: Lyme X Phase 3 winners will be announced soon.)

While an accurate Lyme diagnostic is absolutely needed, I cannot ignore the fact that ticks in North America are known to transmit over 18 different pathogens.

In August of 2024, a team of biologists at City University of New York Graduate Center produced a genetic analysis of 47 different strains of Borrelia. This may pave the way for improved diagnosis, treatment, and prevention of Lyme disease.

I hope that with this new genetic mapping, we will finally be able to take advantage of the next-generation metagenomic testing which is capable of detecting multiple pathogens.

Treatment

One of the top priorities of patients with chronic Lyme disease is finding an effective treatment.

Two recent studies have shown that combination therapy for Lyme, and combination therapy for Babesia work better than monotherapy.

But not everyone responds favorably to pharmaceuticals. One reason for this, may be a condition called alpha-gal syndrome (AGS).

AGS is triggered by the bite of a tick and causes an allergy to anything derived from red meats including some medications. An estimated 450,000 people have AGS in the U.S., making it the tenth most common food allergen.

If enacted, the Alpha-Gal Inclusion Act would require the FDA to list alpha-gal as a major allergen and require labeling to include it as an ingredient.

Mast cell activation syndrome

Another complicating factor common in patients with chronic Lyme is mast cell activation syndrome (MCAS). MCAS can make patients extremely sensitive to certain types of chemicals, foods and additives.

In fact, MCAS is such an important topic, in 2024 we devoted an entire issue of the Lyme Times to Mast Cell Activation Syndrome which you can download and read for free.

Alas, there is nothing simple about treating complex medical conditions triggered by the bite of a tick. Many of the patients I know who’ve gotten better took years before they found the root cause of their misery followed by the right combination of treatment that worked.

In 2023 we devoted an entire issue of the Lyme Times trying to answer the question: What does it take to get better?

My hope is that we continue to see scientific progress in finding better diagnostics and treatment. And if you are struggling with a chronic illness, please do not give up hope.

LymeSci is written by Lonnie Marcum, a physical therapist and mother of a daughter with Lyme. She served two terms on a subcommittee of the federal Tick-Borne Disease Working Group. Follow her on X: @LonnieRhea   Email her at: lmarcum@lymedisease.org.

_______________

**Comment**

To my knowledge, treating this complex illness has hardly moved forward in over 40 years.  The medical industrial complex is myopically focused on ‘vaccines,’ which are big money makers for both Big Pharma and the government, which owns patents on many aspects of them.  As long as this remains the singular focus, patients will not be treated properly.  Further, as long as ‘consensus basedmedicine reigns, innovative doctors who dare to use their God-given brains to help patients will continue to be persecuted, leaving patients to suffer.  As it is, the only true help for Lyme/MSIDS is to get to an independent, trained, and experienced Lyme literate doctor.

For more:

Letter Breaking Down Timeline & Deception of Lyme Disease: No Studies Have Ruled out Sexual Transmission

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/

Question for Aaron Siri, Managing Partner Siri & Glimstad

Carl Tuttle
Hudson, NH, United States
Dec 18, 2024

If antibiotic resistance was acknowledged early on by our Public Health Officials as it was by Dr. Allen Steere in 1977 the focus would have been on developing new antimicrobials (or different combinations) as seen in the treatment of Brucellosis but the potential money grab from a Lyme vaccine was far too lucrative to pass up. Everything about Lyme from that point forward had to support vaccine development. A chronic relapsing SERONEGATIVE disease did not fit the vaccine model. The money orgy produced by vaccines could not be more obvious through recent Covid events. The rest of the world now has a bird’s eye view of what our Public Health Officials are capable of when a false narrative has been dictated. The disabled Lyme community has been shouting from the rooftops for decades and everyone reading this knows of someone severely affected from Lyme disease; shame on you for not speaking up!

The following letter to Aaron Siri, Managing Partner of Siri & Glimstad breaks down the timeline and deception. Attorney Siri recently exposed the truth/facts about childhood vaccines through the depositions of Stanley Plotkin world’s leading authority on vaccines and Dr. Kathryn Edwards world’s leading vaccinologist.

Letter to Attorney Siri:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “aaron@sirillp.com” <aaron@sirillp.com>
Cc: “mbarney@sirillp.com” <mbarney@sirillp.com>, “ebrehm@sirillp.com” <ebrehm@sirillp.com>, “ddisabato@sirillp.com” <ddisabato@sirillp.com>, “lconsidine@sirillp.com” <lconsidine@sirillp.com>, “wmoller@sirillp.com” <wmoller@sirillp.com>, “mconnett@sirillp.com” <mconnett@sirillp.com>, “ahaskins@sirillp.com” <ahaskins@sirillp.com>, “cxenides@sirillp.com” <cxenides@sirillp.com>
Date: 12/13/2024 12:29 PM EST
Subject: Question for Aaron Siri, Managing Partner Siri & Glimstad

Siri & Glimstad
Aaron Siri, Managing Partner

Dear Attorney Siri,

When and who ruled out sexually transmitted Lyme disease?

Hold that thought for one moment please….

Weren’t we told by IDSA/Eugene Shapiro that there has never been one case of congenital Lyme? WRONGWRONG!

Weren’t we told by the New York Times that Lyme is “hard to catch and easy to halt”? WRONG!

Weren’t we told by Wormser that persistent symptoms are nothing more than the aches and pains of daily living? WRONG!

Weren’t we told by Mainstream media that LYMErix was taken off the market due to poor sales? WRONG!

Weren’t we told by the CDC/IDSA that the bulls-eye rash appears 80% of the time?  WRONG!

Weren’t we told by the CDC/IDSA Paul Auwaerter that the two-tier Lyme test is a good test?  WRONGWRONG!

Weren’t we told by Wormser that single dose Doxycycline as a prophylaxis after tick bite is sufficient in stopping the disease? WRONG!

Weren’t we told by the CDC/IDSA that there’s no Lyme disease in the south?  WRONG!

Weren’t we told by the CDC/IDSA that it takes 48hrs of tick attachment before the disease can be transmitted. WRONGWRONG!

Weren’t we told by the (CDC/IDSA/ALDF) that there is no toxin involved in Lyme disease? WRONG! Again.

So what else have they gotten wrong??

Getting back to my original question: “sexually transmitted Lyme disease” ...

The 2014 study below found culture positive evidence of Borrelia spirochetes in the genital secretions of these patients:

Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions
https://pmc.ncbi.nlm.nih.gov/articles/PMC5482345/

Conclusions:  The culture of viable Borrelia spirochetes in genital secretions suggests that Lyme disease could be transmitted by intimate contact from person to person. Further studies are needed to evaluate this hypothesis.

Here is the CDC’s stance on sexually transmitted Lyme disease:

About other modes of transmission
https://www.cdc.gov/lyme/causes/index.html

There is no credible scientific evidence that Lyme disease is spread through touching, kissing, or sexual contact. Published studies in animals do not support sexual transmission (Moody 1991; Woodrum 1999), and the biology of the Lyme disease spirochete is not compatible this route of exposure (Porcella 2001).

Carl Tuttle’s comment: ONE SINGLE PUBLICATION 23 YEARS AGO! This is not an actual study proving or ruling out sexual transmission; this is one man’s perspective using the words “suggest/suggests/suggesting.”

Don’t look!  That assures you won’t find!

Isn’t that exactly what you just exposed Attorney Siri in the depositions of Stanley Plotkin and Dr. Kathryn Edwards regarding the vaccine and autism debate? There have been no autism studies for the childhood vaccine schedule to challenge the mantra “Vaccines Do Not Cause Autism because we say so.”

There have been no studies to rule out sexually transmitted Lyme disease so how much sexually transmitted Lyme has been circulating in the public for the past three decades or more?

In 2003 Texas physicians Harvey and Salvato tested their chronically ill patients for Lyme disease via CDC Western blot criteria finding all patients positive for the infection in a state where the prevalence of Lyme infected ticks is only about 1-2%. “No history of bull’s-eye rash or illness following tick bite was reported by these patients.” The CDC defines “Lyme disease” exclusively as a zoonotic illness. Congenital and gestational transfer cases have been disregarded for reasons not evident to us.”

Here is an example of how other infections have been managed:

Chronic Brucellosis and Persistence of Brucella melitensis DNA
https://www.ncbi.nlm.nih.gov/pubmed/?term=Chronic+Brucellosis+and+Persistence+of+Brucella+melitensis+DNA

After acute brucellosis infection, symptoms persist in a minority of patients for more than 1 year. Such patients are defined as having chronic brucellosis. Since no objective laboratory methods exist to confirm the presence of chronic disease, these patients suffer delays in both diagnosis and treatment.

Why haven’t we done this with Borrelia burgdorferi infection…..

1. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
https://www.ncbi.nlm.nih.gov/pubmed/25246401

The doxycycline-streptomycin-rifampin regimen eliminates Brucella DNA more efficiently than doxycycline-streptomycin, which may result in superior long-term clearance of Brucella.

2. Different Clinical Presentations of Brucellosis.
https://www.ncbi.nlm.nih.gov/pubmed/27284398

It was once believed that rifampin was curative in treating Brucellosis but when symptoms returned doxycycline was added to the mix and when that too failed a third antibiotic, streptomycin was added to the current treatment regimen.

In contrast, oral amoxicillin or doxycycline remains the treatment of choice for treating Lyme disease for over thirty years regardless if debilitating symptoms return. Dr. Allen Steere knew that these antibiotics were not effective for all patients (see 1977 reference) but there has been no change in treatment or research to find more effective ways to eradicate the infection in all stages of disease.

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. (1977)  https://pubmed.ncbi.nlm.nih.gov/836338/

Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM.

Excerpt:

“The best treatment for this illness is not clear. Some physicians have reported that penicillin or tetracycline results in disappearance of the skin lesion (41,42), but others find antibiotics ineffective. Four of the patients with expanding skin lesions received penicillin but still developed arthritis.”

In contrast, the only action item we have in the pipeline after FORTY years for Lyme disease is a vaccine fast-tracked by the FDA in 2017. Since all the eggs have been put into the vaccine basket it would appear that our Health Agencies are in the shot business with annual revenue of $4.3 billion from the sales and patent royalties.

A chronic relapsing seronegative disease DOES NOT fit the vaccine model because you cannot prove vaccine efficacy in a disease where we don’t know who has or does not have the infection! So, deny the chronically infected by suppressing all evidence of antibiotic resistance, claim that the infection is easily treated because newer curative treatment for all stages of disease would give the public an excuse not to take the vaccine, reject all direct-detection methods that prove chronic infection and voila! move forward with patent royalties, vaccine development and pharmaceutical profits. The federal watchdog is no more. People suffering and dying and for what? Lyme for Profit.

The CDC has propagated this false Lyme disease narrative for decades and to this day refuses to recognize the disabling stage of the disease exposed in the documentaries Under our Skin and The Quiet Epidemic.

Suppressing evidence of antibiotic resistance for the sake of a vaccine is a crime Attorney Siri!

This is a criminal case that must be exposed as you have done with the childhood vaccine mantra; “Vaccines do not cause autism because we say so.”

Chronic Lyme does not exist because we say so! DO NOT QUESTION OUR PUBLIC HEALTH NARRATIVE, PERIOD!!! Or else…

We need your help Attorney Siri! We need your help!

Respectfully submitted,

Carl Tuttle
Independent Researcher
Lyme Endemic Hudson, NH

PS. Publication from our public health officials of Vector Borne Division of the CDC:

Post-treatment Lyme borreliosis in context: Advancing the science and patient care
Grace E. Marx*, Alison F. Hinckley, Paul S. Mead

Published 27 June 2021
https://www.thelancet.com/pdfs/journals/lanepe/PIIS2666-7762(21)00130-7.pdf

Tuttle’s comment:

This is the same old garbage (junk science) regurgitated by the CDC/IDSA year after year, decade after decade while avoiding the elephant in the room.

Conclusion: “Fortunately, safe and effective vaccines for Lyme disease may be on the horizon which could both reduce LB incidence on a population scale while averting long-term patient suffering”  Voila and there you have it folks!!!!

_________________

**Comment**

Our case is a perfect example of sexual transmission.  For our story:   https://madisonarealymesupportgroup.com/2017/02/24/pcos-lyme-my-story/

Lida Mattman was able to culture spirochetes from tears, sweat, urine, CSF, blood, plasma, fleas, mites, mosquitoes, etc. and UW researcher Elizabeth Burgess could infect cats orally, ocularly, via IV, and via contact transmission in dogs:  https://madisonarealymesupportgroup.com/2019/04/02/transmission-of-lyme-disease-lida-mattman-phd/  She almost lost her job over these findings because they didn’t want them found.

Medical Detective: An Overview of Lyme Disease Signs and Symptoms

https://www.lymedisease.org/overview-lyme-signs-symptoms/

MEDICAL DETECTIVE: An overview of Lyme disease signs and symptoms

This article was originally posted on Dr. Richard Horowitz’s Medical Detective Substack. You can find more helpful content by subscribing to it here.

Now that you know that Lyme disease presents a regular risk for you and your family due to its worldwide spread, rapidly increasing tick populations due to a warming climate (ticks reproduce faster at higher temperatures), and lack of accurate testing, what are the most common Lyme symptoms, aside from the telltale rash, that you should be looking for to suspect an infection?

Signs and Symptoms of Lyme Disease

There are six major signs and symptoms that allow the Medical Detective to suspect an infection with Borrelia burgdorferi, the agent of Lyme disease:

(1) It is a multisystemic illness. Although it is possible to just have one joint that hurts and may be swollen as your primary symptom, this is not the usual manifestation that I have seen among the 13,000 chronically ill individuals I have diagnosed and treated. A broad range of body systems is usually affected, including the heart, musculoskeletal system, along with neurological, psychological, hormonal, and even immunological consequences, including immune deficiency.

So if you have a multisystemic illness, with many of the symptoms listed below, and your doctor has sent you to specialist after specialist looking for answers, that is a telltale sign Lyme disease may be present.

(2) Symptoms of Lyme disease tend to come and go with good and bad days. In many other chronic illnesses, symptoms tend to be daily without huge variations in intensity or frequency.

(3) The hallmark symptom of Lyme disease is migratory pain. Migratory joint pain, migratory muscle pain and/or migratory nerve pain (neuropathy, which is usually experienced as a burning, tingling, numbness or stabbing sensation) lets the Medical Detective know that a diagnosis of Lyme is likely. (There are only seven diseases that cause migratory pain.)

(4) Symptoms of Lyme disease usually get better or worse with antibiotics. This would not be the case with a chronic fatiguing, musculoskeletal, cardiac, neuropsychiatric illness due to a pure viral infection (which can be the case in CFS/ME, FM, and/or long Covid). Symptoms that can get better (lowering the load of the bacteria) or worse (known as a Herxheimer reaction, which is an inflammatory reaction due to killing off of the bacteria) include the following:

*Muscle and joint pain (which can be migratory in nature)

*Severe fatigue

*Tingling and/or numbness/and/or burning and/or stabbing sensations (neuropathy, which can be migratory in nature)

*A stiff neck

*Headaches

*Light and sound sensitivity

*Dizziness

*Memory and concentration problems

*Mood disorders such as depression and/or anxiety

*Difficulty falling asleep and staying asleep

*Fever and/or chills

*Gastrointestinal issues

*Chest pain with palpitations

*Shortness of breath…and more.

*(I’ll have more details about symptoms in my next article.)

(5) Women usually have a worsening of Lyme disease symptoms around their menstrual cycle: before, during or right afterwards. This is because when estrogen levels drop, the bacteria can become more active.

(6) Finally, there are clues on blood tests that you have been exposed to Lyme disease and associated tick-borne infections, but it is important to know that standard two-tiered testing (STTT), using an ELISA followed by a Western blot–one of the primary ways doctors try to diagnose Lyme disease–is highly insensitive, with the accuracy of about a coin flip.

Insensitive testing

For early Lyme disease, doctors may use a version of the STTT, called “Modified two-tiered testing (MTTT),” where two enzyme immunoassays (EIAs) are used instead of the traditional Immunoblot. (Although in one Canadian study it was 25% better at diagnosing some early cases, it is still an imperfect test, and other studies have found the MTTT to be more or less equivalent to the STTT.)

Which means that, ultimately, Lyme disease is a clinical diagnosis. An EM rash, the classic rash of Lyme disease, is proof of exposure and does not require a positive blood test. But if you did not see the rash, you need to know that negative testing with a STTT and/or a MTTT does not rule out exposure.

Clues that you have been exposed are Borrelia specific bands in your blood, such as the 23 kDa (Outer surface protein C, i.e., Osp C), 31 kDa (Osp A), 34 kDa (Osp B), 39 kDa and the 83/93 kDa bands. The exception is the 31 kDa band on a Western blot may cross react with viral proteins or reflect an autoimmune process. The 31 kDa band on an Immunoblot, a test that uses recombinant DNA, is however specific, which is why we prefer using Immunoblots as our first line test.

Standard treatment for Lyme disease

Because testing and treatment can be so complicated, there’s much more info to come….

For now, know that if caught early, the standard treatment for Lyme by some infectious disease doctors is a 14-day course of antibiotics, usually doxycycline or amoxicillin. For an EM rash, some doctors will prescribe antibiotics for up to 30 days.

However, if you have multiple EM rashes, or an EM rash with peripheral nervous system (PNS) involvement (tingling, numbness, burning, and/or stabbing sensations of the arms and legs) and/or central nervous system (CNS) involvement with nerve palsy like Bell’s palsy (where your facial muscles don’t work properly) with associated neuropathy, cognitive difficulties with memory/concentration problems, light or sound sensitivity, dizziness, sleep disorders, new or exacerbated psychological symptoms–short courses of antibiotics will not clear the infection, and you will go on to the chronic form of the disease.

When symptoms persist–Stephen’s story 

If symptoms persist, brace yourself! You could find yourself at the mercy of the bacteria that will make your life a misery. Like Stephen.

When Stephen came to see me in March 2020, he told me he’d had to drop out of his first semester at college because he couldn’t function anymore. He’d been suffering for 10 years—no, that is not a typo!–from a strange disease that had brought his life to a halt, going from one doctor to another trying to find a cure.

When I asked him to describe his symptoms, he took a deep breath. The list was long. “Well, I’m tired all the time, no matter what I do,” he told me. “My joints and muscles always ache. I get these sharp stabbing pain in my hands or legs or chest. Sometimes it’s a burning pain.” He shook his head, confused. After all these years, he still couldn’t understand why this was happening. It didn’t make sense.

Working on a theory, I asked if he experienced shortness of breath or night sweats. He did. But then, carefully avoiding my eyes, he confessed to the worst symptom of all. “Sometimes —not always—I see or hear things that aren’t really there.”

My heart went out to him. This bright young man with such a promising future had suddenly developed auditory and visual hallucinations when he was 18 for no apparent reason. A psychiatrist decided he was schizophrenic, and prescribed an antipsychotic that came with serious side effects. Once Stephen had this diagnosis, no doctor had ever listened to him the same way again. Until now.

An important piece of the puzzle

“Have you ever been around cats?” I asked him.

“Not lately,” he said. Then he remembered that, growing up in rural Pennsylvania, he’d had a cat. Inevitably, she had scratched and bitten him more times than he could remember.

“How about tick bites?”

“Sure,” he said. “But that was years ago…”

As I questioned him, the pieces of the medical puzzle started to fall into place. I’d seen the same series of infectious and environmental assaults in patients with this illness for decades. I thought it might also stem from the same infections.

When I asked Stephen to stand up for the physical exam, he felt dizzy. I checked his pulse. It had jumped more than 30 beat per minute and stayed high for several more minutes.

That was a clear sign of POTS (Postural Orthostatic Tachycardia Syndrome), a dysregulation in areas of the nervous system that controls our blood pressure and pulse rate. I see this problem regularly in my chronic Lyme disease patients, those suffering from long Covid, as well as those with problems due to environmental toxins like mold.

When he lifted his shirt so I could listen to his lungs, Stephen muttered, apologetically, “Oh, I have a rash…” That was an understatement. Spreading across his entire middle and upper back was a distinctive purple rash that looked like horizontal stretch marks.

I smiled. “I need to confirm it with blood tests, but I think I know what’s causing your symptoms.”

Stephen was stunned. “What is it?”

“A parasite,” I told him. “It’s called Babesia. It’s a protozoan, like malaria, that can cause sweats, chills, shortness of breath. And I also strongly suspect you have contracted a bacterial infection called Bartonella, often transmitted through cat bites and scratches.”

When we got his laboratory results back, they confirmed my suspicions. “Bartonella could’ve caused all of your neuropsychiatric symptoms—and the rash!” I told him.

Other factors

That said, a condition as extreme as Stephen’s is not just about parasites and little-known bacterial infections. There were a lot of contributing factors. He’d been exposed to environmental toxins like mold, along with vitamin and mineral deficiencies, and this had exacerbated and compounded his symptoms, preventing his immune system from clearing away any lingering infections and making it difficult for him to detoxify and improve.

With so many things going on, it was clear that Stephen didn’t just have Lyme disease. He had Multiple Systemic Infectious Disease Syndrome (MSIDS). He had multiple overlapping sources of inflammation with downstream effects making him ill.

When I started Stephen’s treatment, using dapsone combination therapy for chronic Lyme disease and Bartonella, he soon felt like a completely different person. For the first time in over a decade, his pain was gone. His joint and muscles didn’t ache. The stabbing, burning nerve pains had disappeared. No more night sweats (we will devote an entire article to Babesia in the future). No fatigue.

Even the hallucinations were almost gone. After struggling to regain his health for so long that he had nearly given up hope, Stephen was almost completely back to normal — in months — after finally getting the right treatment.

And you can get the right treatment too.

More to come

In upcoming articles, I’m going to talk much, much more about MSIDS, and the 16-point treatment plan that I used my Medical Detective skills to develop. It’s a treatment plan that works for not only chronic Lyme disease, but many other chronic illnesses which share overlapping biological processes with the three I’s: multiple infections, inflammation, and immune dysfunction.

Coming up next, I’m going to share the Lyme questionnaire, taken from my book. How Can I Get Better? and published in the International Journal of General Medicine. We validated this questionnaire in 1,600 individuals, both healthy and sick, with help from researchers at the State University of New Paltz. I know it’s going to help if you worry at all that you or someone you know might have Lyme disease. Then, in future articles, we are going to dive into the broad range of testing available to help diagnose early and late disease.

This article was originally published on Substack by Dr. Richard Horowitz. 

Dr. Richard Horowitz has treated 13,000 Lyme and tick-borne disease patients over the last 40 years and is the best-selling author of  How Can I Get Better? and Why Can’t I Get Better? You can subscribe to read more of his work on Substack or join his Lyme-based newsletter for regular insights, tips, and advice.

For more:

Symptoms After Lyme: What’s Past is Prologue

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/33044899?

Symptoms after Lyme disease: What’s past is prologue (Adriana Marques, M.D.)

Carl Tuttle
Hudson, NH, United States
Nov 17, 2024

Please see the following email addressed to Dr. Adriana Marques, Chief of the NIAID Lyme Disease Studies Unit regarding her recent viewpoint published in the journal Science Translational Medicine. The Editorial Staff was Cc’d on this email.

Senior Editor Courtney Malo, Ph.D. responded to my inquiry and is posted below followed by my final comment.

Photo of Marques was found on the following NIH site:
https://www.niaid.nih.gov/research/adriana-marques-md

Inquiry to Adriana Marques:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “amarques@niaid.nih.gov” <amarques@niaid.nih.gov>
Cc: “osmith@aaas.org” <osmith@aaas.org>, “mnorton@aaas.org” <mnorton@aaas.org>, “ccharneski@aaas.org” <ccharneski@aaas.org>, “cmalo@aaas.org” <cmalo@aaas.org>, “bberry@aaas.org” <bberry@aaas.org>, “dhallberg@aaas.org” <dhallberg@aaas.org>, “dneuhofer@aaas.org” <dneuhofer@aaas.org>, “mogle@aaas.org” <mogle@aaas.org>
Date: 11/14/2024 9:54 AM EST
Subject: Symptoms after Lyme disease: What’s past is prologue

SCIENCE TRANSLATIONAL MEDICINE

13 Nov 2024

Symptoms after Lyme disease: What’s past is prologue
ADRIANA MARQUES
https://www.science.org/doi/10.1126/scitranslmed.ado2103

There have been five randomized, placebo-controlled, double-blind clinical trials addressing the question of whether additional antibiotic treatment benefits patients with PTLDS or symptoms attributed to Lyme disease.”

“The results of these trials showed that prolonged antibiotic treatment had no lasting benefit while having potential serious risks.”

Adriana Marques, M.D.
Lyme Disease Studies Unit
NIH Main Campus, Bethesda, MD

Dr. Marques,

For the record there are many infections requiring long-term antibiotics so why Klempner stopped his NIH funded antibiotic treatment trials for Lyme after “12 weeks” and then claimed no benefit makes absolutely no sense whatsoever:

From the following peer-reviewed publication:

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease
https://www.dovepress.com/benefit-of-intravenous-antibiotic-therapy-in-patients-referred-for-tre-peer-reviewed-fulltext-article-IJGM

Infections requiring long-term antibiotics: [See chart in the publication above with 8 examples ranging from 6mo to 5yrs]

In 1991 the Lyme disease organism, Borrelia burgdorferi, was grown from the cerebrospinal fluid of Lyme patient Vicki Logan at the Centers for Disease Control in Fort Collins, Colorado despite prior treatment with intravenous antibiotics. The patient died when the insurer refused additional IV antibiotics. Here is a copy of Logan’s CDC positive culture report for your review.

(Vicki Logan’s Chronic Lyme Autopsy results Page #1234567)

There are 700 peer-reviewed publications referencing persistent infection and in a 2018 study all patients were culture positive even after multiple years on antibiotics so there was no relief from current antimicrobials. Some of these patients had taken as many as eleven different types of antibiotics.

Thirty-four years ago Dr. Allen Steere identified chronic Lyme disease which should have set off a red flag prompting an immediate search for better antimicrobials but then did a 180° as he became principal investigator (PI) of the Phase 3 clinical trial for the first Lyme disease vaccine. So all the eggs were put into the vaccine basket while a campaign was orchestrated to discredit the sick and disabled patient population along with the courageous clinicians attempting to help these patients. Apparently, a chronic relapsing seronegative disease did not fit the business model of patent royalties, vaccine development and pharmaceutical profits.

Here is Dr. Steere’s 1990 publication summary for your review:

The New England Journal of Medicine 

Published November 22, 1990

Chronic neurologic manifestations of Lyme disease
https://www.nejm.org/doi/full/10.1056/NEJM199011223232102

The chart below summarizes Lyme research funded by the NIH and only 2.5% has been allocated for treatment: [Click on link to view the chart]

Question:

Is there a reason why these facts/references/lab reports are missing from your viewpoint published in Science Translational Medicine?

A response to this inquiry is requested.Carl Tuttle
Independent Researcher
Hudson, NH USA

Cc: Orla M. Smith, Ph.D. Editor, Science Translational Medicine

Editorial Staff

Melissa Norton, M.D.

Catherine A. Charneski, Ph.D.

Courtney S. Malo, Ph.D.

Brandon Berry, Ph.D.

Dorothy L. Hallberg, Ph.D.

Daniela Neuhofer, Ph.D.

Molly Ogle, Ph.D.

Response from Senior Editor Courtney Malo, Ph.D.

———- Original Message ———-
From: Courtney Malo <cmalo@aaas.org>
To: CARL TUTTLE <runagain@comcast.net>
Cc: “Marques, Adriana (NIH/NIAID) [E]” <amarques@niaid.nih.gov>, Orla Smith <osmith@aaas.org>
Date: 11/14/2024 11:26 AM EST
Subject: Re: Symptoms after Lyme disease: What’s past is prologue

Dear Dr. Tuttle,

Thank you for your email in response to the viewpoint “Symptoms after Lyme disease: What’s past is prologue” published in Science Translational Medicine.

We suggest that you submit your comments as an eLetter via our website. To do so, please go to the paper under discussion (https://www.science.org/doi/10.1126/scitranslmed.ado2103 and navigate to the “eLetters” option at the very bottom of the page. Our eLetters platform provides a dynamic and rapid way for readers to provide feedback on the papers we publish and to elicit discussion.

Sincerely,
Courtney Malo

Courtney Malo, Ph.D. (she/her/hers)

Senior Editor

Science Translational Medicine

cmalo@aaas.org |  https://www.science.org/journal/stm

My final reply:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: Courtney Malo <cmalo@aaas.org>
Cc: “Marques, Adriana (NIH/NIAID) [E]” <amarques@niaid.nih.gov>, Orla Smith <osmith@aaas.org>, “mnorton@aaas.org” <mnorton@aaas.org>, “ccharneski@aaas.org” <ccharneski@aaas.org>, “bberry@aaas.org” <bberry@aaas.org>, “dhallberg@aaas.org” <dhallberg@aaas.org>, “dneuhofer@aaas.org” <dneuhofer@aaas.org>, “mogle@aaas.org” <mogle@aaas.org>
Date: 11/16/2024 8:15 AM EST
Subject: Re: Symptoms after Lyme disease: What’s past is prologue

On 11/14/2024 11:26 AM EST Courtney Malo <cmalo@aaas.org> wrote: “We suggest that you submit your comments as an eLetter via our website.”

Dear Dr. Malo,

Thank you for responding to my email. Is my submitted eLetter in the process of being screened?

I would like to call attention to the following 1992 Science article that was listed directly below Dr. Marques’ published viewpoint:

Furor at Lyme Disease Conference: Patient-support groups got a dozen rejected papers reinstated at a Lyme disease meeting, angering researchers who had turned the work down as unscientific
https://www.science.org/doi/10.1126/science.1604309

Excerpt:

To some authors of the controversial abstracts the grudging acceptance is too little too late, from a close-minded research community. “If [a finding] is not part of a controlled study, they ignore it,” says Long Island internist Burascano.

Dr. Malo,

Isn’t that exactly what I am questioning 32 years later? I am asking Marques why the peer-reviewed references I provided are missing from her published viewpoint:

My question to Marques:

“Is there a reason why these facts/references/lab reports are missing from your viewpoint published in Science Translational Medicine?”

It would appear that the act to suppress evidence of chronic Lyme disease spans three decades. How many lives have been destroyed resulting from inadequate treatment?

It is not uncommon for these corresponding authors to ignore serious inquires. One example is from my 2020 BMJ Letter to the Editor below. It should be noted that the corresponding author refused to respond to my inquiry after multiple requests from Editor-in-Chief Dr. Fiona Godlee.

Letter to the Editor of the BMJ published June 2020 
https://www.bmj.com/content/369/bmj.m1041/rr-1

Dr. Malo…. Has your journal been used as a podium to broadcast the long-established dogma while omitting evidence of persistent infection after extensive antibiotic treatment?

Respectfully submitted,
Carl Tuttle

_______________
**Comment**
Must thanks to patient and advocate Carl Tuttle for his tireless efforts dealing with knot-heads.  Kudos to you for having the patience of a saint.